ARTICLE PDF (Українська)


telomere length, telomerase activity, oxidative stress, cerebral atherosclerosis

How to Cite

Yehorova, M. S., Krasnienkov, D. S., Gurianov, V. G., Kondratiuk , V. Y., & KuharskiyV. М. (2019). RELATIONSHIP OF TELOMERE LENGTH, TELOMERASE ACTIVITY, AND OXIDATIVE STRESS MARKERS IN PATIENTS WITH CEREBRAL ATHEROSCLEROSIS AND TYPE 2 DIABETES. Clinical and Preventive Medicine, (3-4), 117-127.


The aim of study is to determine the relationship between telomere length and telomerase activity with indicators of oxidative stress in patients with stage 1-3 cerebral atherosclerosis and type 2 diabetes.

Material and methods. A total clinical and instrumental study involved 161 patients with grade 1–3 CA. Telomerase activity was determined using a tandem repeat amplification protocol with real-time detection. The relative telomere lengths were measured using real-time multiplex quantitative polymerase chain reaction.

Results. A comparative analysis revealed that patients with stage 1-3 CA with long telomeres had a significantly higher catalase level than in the short telomere group, and the catalase and SOD levels in the group with high telomerase activity were significantly lower than in the group with low telomerase activity. A correlation analysis revealed significant direct relationships between telomere length and oxidative stress markers such as catalase and SOD (r = 0.23 and r = 0.21, respectively) and telomerase activity with GSH (r = 0.48). An inverse relationship between the telomere length and T2DM (r = -0.21) was also revealed. Telomere length and telomerase activity were not correlated with other markers of oxidative stress.

Conclusion. In patients with stage 1-3 cerebral atherosclerosis, an association of some markers of oxidative stress (catalase, SOD, GSH) with telomere length and telomerase activity, regardless of the presence of concomitant type 2 diabetes mellitus, was revealed. In patients with stage 1-3 cerebral atherosclerosis with longer telomeres, catalase levels are statistically significantly higher than in patients with short telomeres. Stage 1-3 cerebral atherosclerosis patients with higher telomerase activity are characterized by statistically significantly lower levels of catalase and superoxide dismutase compared with patients with lower telomerase activity. The most stable direct correlation in this category of patients was found between GSH and telomerase activity (r = 0.48), which may indicate the key role of GSH in the rate of telomere shortening and the development of atherosclerosis.
ARTICLE PDF (Українська)


Banerjee, P. and Jagadeesh, S. (2009). Non-Radioactive Assay Methods for the Assessment of Telomerase Activity and Telomere Length. Methods in Molecular Biology, 1, 383-394.

Bekaert S, De Meyer T, Rietzschel ER et al. (2007). Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell, 6, 639–647.

Benetos A., Kark J. D., Susser E. et al. (2013). Trackin and fixed ranking of leukocyte telomere length across the adult life course. Aging Cell, 12, 615–621.

Benetos A., Toupance S., Gautier S., Labat C., Kimura M., Rossi P., Settembre N., Hubert J., Frimat L., Bertrand B., Boufi M., Flecher X., Sadoul N., Eschwege P., Kessler M., Tzanetakou I., Doulamis I., Konstantopoulos P., Tzan, A., Koro, M., Gkogkos A., Perreas K., Menenakos E., Samanidis G., Vasiloglou-Gkanis M., Kark J., Malikov S., Verhulst S., Aviv, A. (2018). Short Leukocyte Telomere Length Precedes Clinical Expression of Atherosclerosis. Circulation Research, 122(4), 616-623.

Cawthon R. (2009). Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Research, 37(3), e21-e21.

Das B. K., Sun T. X., Akhtar N. J., Chylack L. T. Jr, Liang J. J. (1998). Fluorescence and immunochemical studies of advanced glycation-related lens pigments. Invest Ophthalmol Vis Sci., 39(11), 2058-2066.

De Meyer et al. (2018). Telomere Length as Cardiovascular Aging Biomarker: JACC Review Topic of the Week. JACC, 72(7), 805–813.

De Meyer T., Rietzschel E. R., De Buyzere M. L., et al. (2009). Systemic telomere length and preclinical atherosclerosis: the Asklepios Study. Eur Heart J, 30, 3074–3081.

Fiorenza Magi, Ivan Dimauro, Fabrizio Margheritini, Guglielmo Duranti, Neri Mercatelli, Cristina Fantini (2018). Telomere length is independently associated with age, oxidative biomarkers, and sport training in skeletal muscle of healthy adult males. Free Radic. Res., 52 (6), 639-647

Góth L. (1991). A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta., 196(2-3),143-151.

José Santiago Ibáñez-Cabellosa, Giselle Pérez-Machadob, Marta Seco-Cerveraa ,Ester Berenguer-Pascualb, José Luis García-Giméneza, Federico V. Pallardóa (2018) Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening. Redox Biology, 14, 398–408.

Koriath M., Müller C., Pfeiffer N., Nickels S., Beutel M., Schmidtmann I., Rapp S., Münzel T., Westermann D., Karakas M., Wild P., Lackner K., Blankenberg S., Zeller, T. (2019). Relative Telomere Length and Cardiovascular Risk Factors. Biomolecules, 9(5), 192.

Kostyuk V. A., Potapovich A. I. (1989). Superoxide-driven oxidation of quercetin and a simple sensitive assay for determination of superoxide dismutase. Biochem Int., 19(5), 1117-1124.

Mokrasch L. C., Teschke E. J. (1984). Glutathione content of cultured cells and rodent brain regions: a specific fluorometric assay. Anal Biochem., 140(2), 506-509.

Nettle D., Andrews C., Reichert S., Bedford T., Kolenda C., Parker C., Martin-Ruiz C., Monaghan P., Bateson M. (2017). Early-life adversity accelerates cellular ageing and affects adult inflammation: experimental evidence from the European starling. Sci. Rep. 7, 40794. doi:10.1038/srep40794

Reichert S., STIER A., Zahn S., Arrive´ M., Bize P., Massemin S., Criscuolo F. (2014). Increased brood size leads to persistent eroded telomeres. Front. Ecol. Evol. 2, 10114. doi:10.3389/fevo.2014.00009.

Sambrook J., Russell D. (2006). Purification of Nucleic Acids by Extraction with Phenol: Chloroform. Cold Spring Harbor Protocols, 1, pdb.prot4455.

Toupance S., Labat C., Temmar M., et al. (2017). Short telomeres, but not telomere attrition rates, are associated with carotid atherosclerosis. Hypertension,70, 420–425.

Tüközkan, Nurten, Hüsamettin Erdamar (2006). Measurement of Total Malondialdehyde in Plasma and Tissues by High-Performance Liquid Chromatography and Thiobarbituric Acid Assay. Fırat Tıp Dergisi, 11(2), 88-92.

Wasowicz W., Nève J., Peretz A. (1993). Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem., 39(12), 2522-2526.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.